How the Global Flower Industry is Making Its Workers Sick
They work before dawn, in greenhouses thick with the smell of chemicals, cutting stems by the thousands. They wear gloves when they can get them, masks when they’re told to, and pray the headache fading in by mid-morning doesn’t mean something worse is coming. They are the invisible hands behind the roses on your Valentine’s Day table, the lilies at your mother’s funeral, the gerberas in the hospital waiting room. And in flower-producing nations from Ecuador to Ethiopia, Kenya to the Netherlands, a growing body of evidence suggests that the chemicals keeping those blooms perfect are quietly devastating the people who grow them.
The global cut flower industry is worth an estimated $35 billion annually. It is also one of the most pesticide-intensive agricultural sectors on earth — and the health consequences for its largely female, largely low-income workforce are only beginning to be understood.
A Toxic Cocktail in the Greenhouse
Cut flowers are not food. That distinction has, for decades, allowed flower growers to operate under far looser pesticide regulations than those governing fruit and vegetable production. There are no international residue limits for pesticides on cut flowers equivalent to those protecting food consumers. The logic has been straightforward, if cynical: you don’t eat a rose. What this logic ignores is the people who grow it.
On a typical flower farm, fungicides, insecticides, acaricides, nematicides, and growth regulators may be applied multiple times per week. In Ecuador’s rose-growing highlands around Cayambe and Tabacundo, studies have documented the use of more than 100 different pesticide formulations on a single farm over the course of a year. Many of these belong to chemical classes — organophosphates, carbamates, pyrethroids, dithiocarbamates — with well-established links to neurological damage, endocrine disruption, reproductive harm, and cancer.
Workers enter treated greenhouses hours, sometimes minutes, after spraying. They handle chemically coated stems without gloves. They eat lunch in or near sprayed fields. They carry residues home on their clothing and skin, exposing their children and partners. And they do this year after year, accumulating exposures that no single safety data sheet was designed to evaluate in combination.
“The problem is not one chemical,” says one occupational health researcher who has spent years studying flower workers in Latin America. “The problem is the cocktail — the chronic, simultaneous, low-level exposure to dozens of substances whose combined effects we have almost no data on.”
Ecuador: The Rose Capital’s Hidden Epidemic
Ecuador produces roughly 25% of all roses sold in the United States. Its high-altitude equatorial plateaus — around 2,800 metres above sea level — create near-perfect growing conditions: consistent temperatures, intense sunlight, and rich volcanic soils. They also create year-round growing cycles that demand year-round chemical management.
Research conducted in the Cayambe region has produced some of the most detailed occupational health data on flower workers anywhere in the world. Studies published in peer-reviewed journals including Environmental Health Perspectives and the International Journal of Occupational and Environmental Health have found:
Neurological effects. Flower workers in Ecuador show measurable depression of cholinesterase activity — an enzyme critical to nerve function — consistent with organophosphate and carbamate exposure. Symptoms including headache, dizziness, nausea, blurred vision, and memory problems are reported at significantly higher rates among flower workers than among comparable agricultural populations not working with pesticides.
Reproductive harm. Multiple studies have found elevated rates of spontaneous abortion among female flower workers during periods of high pesticide application. A landmark study published in the Scandinavian Journal of Work, Environment & Health found that women working in Ecuadorian flower production during the first trimester of pregnancy had significantly higher rates of miscarriage than women in unexposed occupations.
Congenital anomalies. Research in flower-growing communities around Cayambe found elevated rates of musculoskeletal birth defects among children born to mothers employed in flower farms, particularly those working in pesticide application or post-harvest chemical treatment.
Dermatological and respiratory conditions. Contact dermatitis, chronic respiratory irritation, and asthma-like symptoms are among the most commonly reported health complaints. Many workers report that symptoms improve during holidays or periods away from the farm and worsen upon return — a classic pattern of occupational exposure.
Rosa Pilataxi, who worked on a rose farm outside Tabacundo for eleven years, describes a gradual deterioration that she did not at first connect to her work. “First it was headaches, every afternoon. Then I started forgetting things — small things, but it frightened me. My hands would shake some mornings. I thought I was just tired.” She was eventually diagnosed with peripheral neuropathy. She is forty-one years old.
Kenya: East Africa’s Flower Powerhouse
Kenya’s Lake Naivasha basin is one of the most important flower-producing regions on earth. The lake’s shores are lined with enormous glasshouses exporting carnations, roses, and alstroemeria to European supermarkets, primarily via Amsterdam’s Aalsmeer flower auction. The industry employs an estimated 500,000 to 700,000 people directly, and many more in ancillary services — making it one of Kenya’s largest formal employment sectors.
It has also been a site of significant public health concern for decades.
Studies conducted by the African Population and Health Research Center and various Kenyan research institutions have found high rates of pesticide-related illness among Naivasha flower workers. A particularly troubling pattern involves the use of methyl bromide, a soil fumigant once widely used on Kenyan flower farms that has been phased out under the Montreal Protocol due to its ozone-depleting properties — but whose neurological legacy persists in workers who were exposed for years before the ban.
Organophosphate poisoning is a recurring feature of medical reports from clinics near flower-producing areas. Dr. James Mwangi, a physician who has practised near Naivasha for two decades, has described treating patients with acute cholinergic crises — the sweating, salivation, muscle fasciculations, and respiratory distress that signal severe organophosphate poisoning — in people who had no idea what chemical had caused their illness, because they had never been told the names of what was being sprayed around them.
The gender dimension is impossible to ignore. The majority of flower farm workers in Kenya — as in Ecuador, Colombia, and Ethiopia — are women. Women are disproportionately assigned to tasks involving direct chemical contact: mixing pesticide solutions, dipping cut stems in preservative and fungicide baths, working in treated greenhouses without adequate ventilation. Pregnancy and lactation create additional vulnerability, and yet paid maternity leave and workplace protections for pregnant workers remain inconsistently enforced across the sector.
Lake Naivasha itself has become an environmental casualty of the industry it sustains. Pesticide runoff from surrounding farms has been linked to algal blooms, fish population decline, and contamination of drinking water sources for surrounding communities — communities that include the families of the very workers growing the flowers.
Colombia: Roses and Risk in the Sabana de Bogotá
Colombia is the world’s second-largest cut flower exporter after the Netherlands, accounting for roughly 70% of all flowers sold in the United States. The Sabana de Bogotá — the high plateau surrounding the capital — hosts thousands of flower farms employing an estimated 130,000 workers directly, the majority of them women.
Colombian flower workers have been the subject of significant academic and journalistic investigation since the 1990s. The Pesticide Action Network has documented widespread use of chemicals classified by the World Health Organization as moderately to highly hazardous in Colombian floriculture, often without adequate worker protection.
A study published in Biomedica, Colombia’s national public health journal, found that flower workers had significantly higher urinary levels of organophosphate metabolites than control populations, and that these levels correlated with self-reported neurological symptoms. Another study found elevated rates of chromosomal aberrations in the blood cells of workers exposed to pesticides — a biomarker associated with increased cancer risk.
Perhaps most disturbingly, research has found that safety knowledge among workers is severely limited. Many workers cannot name the chemicals they work with, do not know their hazard classifications, and have never received formal training in personal protective equipment use. In some operations, protective equipment is available but workers are penalised informally — through lost productivity bonuses — for taking the time to put it on properly before entering treated areas.
The Netherlands: Even the World’s Most Regulated Industry Has Gaps
The Dutch flower industry is often held up as a model of agricultural modernisation and worker protection. The Netherlands is the world’s largest flower exporter by value, acting as the central hub through which much of the world’s cut flower trade flows, and Dutch domestic production — particularly of tulips, chrysanthemums, and pot plants — is subject to EU pesticide regulations among the world’s most stringent.
Yet even here, gaps persist. Research published in the journal Occupational and Environmental Medicine has found elevated rates of non-Hodgkin lymphoma and other haematological cancers among Dutch floriculture workers, consistent with patterns seen in other pesticide-exposed agricultural populations. Greenhouse workers face particular exposure challenges: enclosed environments concentrate pesticide vapours, and the physical warmth of greenhouse work increases dermal absorption.
Migrant workers — many from Eastern Europe and, increasingly, further afield — fill a significant proportion of seasonal labour needs in Dutch horticulture, and face additional vulnerabilities: language barriers that limit access to safety information, precarious employment status that discourages complaint, and housing in farm-provided accommodation that may itself be contaminated.
The Dutch case illustrates a global truth: even where regulations are comparatively robust, the enforcement, monitoring, and occupational health infrastructure needed to protect workers remain imperfect. In countries where regulations are weak or unenforced, the consequences are far more severe.
Ethiopia: The New Frontier
Ethiopia’s flower industry is one of the fastest-growing in the world. The country has become a major supplier to European markets in less than two decades, with production concentrated in the highlands around Addis Ababa and the Rift Valley. The industry is celebrated as an economic development success story — a source of formal employment, foreign exchange, and rural income in a country where all three are urgently needed.
The occupational health infrastructure, however, has not kept pace with the industry’s growth. Regulatory capacity is limited, enforcement is inconsistent, and occupational health research remains sparse. What studies exist paint a concerning picture: a 2019 survey of Ethiopian flower farm workers found that the majority reported working without adequate protective equipment during pesticide application, that nearly half reported symptoms consistent with pesticide exposure in the previous month, and that few had received any formal health and safety training.
The Ethiopian situation reflects a broader dynamic in the global flower industry: as environmental and labour regulations tighten in established producing countries, production migrates toward regions where compliance costs are lower. Workers in these frontier production zones often face the highest exposures with the least protection and the fewest legal remedies.
What the Industry Says — and What the Evidence Shows
The cut flower industry is not without its defenders, and it is not without its reformers. Certification schemes including Rainforest Alliance, GlobalG.A.P., Florverde Sustainable Flowers, and the Fairtrade flower programme have introduced meaningful requirements around pesticide management, worker safety, and environmental protection. Some farms — particularly larger operations supplying major European retailers — have made genuine progress in reducing pesticide loads, improving protective equipment provision, and establishing health monitoring for workers.
Industry representatives point, reasonably, to the difficulty of operating without pesticides in high-value, appearance-sensitive production: a single thrips infestation or botrytis outbreak can destroy an entire crop. They note that certified farms represent a growing proportion of global production. They argue that the alternative — abandoning certification and the export markets that demand it — would leave workers worse off, not better.
These arguments contain truth. But they do not account for the millions of workers on uncertified farms, or for the limitations of certification systems that rely on announced audits, or for the fact that even certified farms regularly use chemicals whose long-term, combined health effects remain poorly understood.
The fundamental problem is one of evidence and accountability. Unlike food crops, cut flowers are not subject to systematic residue monitoring programmes that might create pressure to reduce chemical inputs. Unlike pharmaceutical products, the combination effects of dozens of agricultural chemicals used simultaneously are not tested before they reach the bodies of the people who apply them. And unlike workers in many industrial settings, flower farm workers — overwhelmingly women, overwhelmingly in low- and middle-income countries, overwhelmingly in precarious employment — have limited political power to demand change.
The Researchers Closing the Gap
A network of occupational health scientists, epidemiologists, and public health advocates is working to build the evidence base that the industry and its regulators have largely failed to create.
In Ecuador, researchers at the Universidad Central del Ecuador have conducted longitudinal studies of flower worker health spanning more than a decade, tracking cholinesterase levels, reproductive outcomes, and neurological symptoms in exposed populations. In Kenya, the African Population and Health Research Center has documented the intersection of pesticide exposure, gender, and health access in Naivasha communities. In Colombia, researchers at the Universidad de los Andes have pioneered biomonitoring studies measuring actual chemical body burdens in workers, moving beyond self-reported symptom surveys to objective biological evidence.
Their findings converge on several conclusions: exposure is widespread and chronic; effects are measurable and significant; women bear disproportionate risk; and the current regulatory framework — designed primarily to protect consumers and the environment rather than workers — is inadequate to the scale of the problem.
What Would Change Look Like?
Advocates and researchers working on flower industry health have a clear, if ambitious, agenda.
Mandatory occupational health monitoring — regular cholinesterase testing, reproductive health surveillance, and systematic symptom reporting — should be standard on all commercial flower farms, not a voluntary add-on for certified operations. The data this generates should be publicly reported and independently audited.
Chemical registration for use on cut flowers should require the same human health evidence as chemical registration for food crops. The exemption that has allowed higher-hazard chemicals to be used in floriculture because the product is not consumed has protected industry convenience at the expense of worker health.
Certification standards should include stronger requirements around re-entry intervals — the minimum time between pesticide application and worker re-entry into treated areas — and these requirements should be enforceable and enforced.
And the workers themselves — the women who cut, grade, sort, treat, and pack the world’s cut flowers — should have meaningful access to information about the chemicals surrounding them, meaningful recourse when they are harmed, and meaningful power to refuse unsafe conditions without fear of losing their livelihoods.
The Flowers in the Vase
A rose cut in Ecuador on a Monday can be on sale in a London supermarket by Thursday. In that compressed transit, the farm where it was grown, the hands that cut it, and the chemicals that kept it blemish-free become invisible. The consumer sees a flower. The label may say “Fairtrade” or carry a certification logo. What it will not say is anything about the woman who cut that stem, whether she had gloves on, whether she knew what had been sprayed that morning, whether her hands shake now in a way they didn’t five years ago.
The global flower industry is not uniquely villainous. It operates within a system of global trade, regulatory arbitrage, and consumer preference for cheap, perfect products that it did not create and cannot single-handedly reform. But it can be held to a higher standard than it currently meets — and the women bearing the cost of its current standard deserve nothing less.
Beauty, the industry’s oldest promise, should not come at the price of the health of the people who make it possible.
Some worker names have been changed to protect employment status.
0 responses to “The Hidden Cost of Beauty”